Fosfomycin Oral Suspension

DRUG2 trials

Sponsors

Public Health Service of Amsterdam, Centre Hospitalier Universitaire de Besancon

Conditions

GonorrheaUrinary Tract Infections

Phase 2

Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM)

Centre Hospitalier Universitaire de BesanconUrinary Tract Infections

Start: 2019-04-30End: 2021-09-30Target: 25Updated: 2019-03-11

Phase 3

New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea

CompletedNCT03294395

Public Health Service of AmsterdamGonorrhea

Start: 2017-09-18End: 2020-06-05Updated: 2021-08-06

Related Papers

Diarrhoea as a frequent adverse event after intramuscular ertapenem treatment for uncomplicated <i>Neisseria gonorrhoeae</i>: a secondary analysis from the NABOGO trial.

2026-01-16

Spontaneous clearance of asymptomatic anogenital and pharyngeal <i>Neisseria gonorrhoeae</i>: a secondary analysis from the NABOGO trial

Sexually Transmitted Infections2022-07-1210 citations

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.

2022-01-1935 citations